Association of Hidradenitis Suppurativa With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

被引:110
作者
Chen, Wei-Ti [1 ,2 ]
Chi, Ching-Chi [2 ,3 ]
机构
[1] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan
[2] Chang Gung Mem Hosp, Dept Dermatol, 5 Fuxing St, Taoyuan 33305, Taiwan
[3] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
关键词
GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; PATHOGENESIS; RISK; COMORBIDITIES; MICROBIOME; PREVALENCE; BACTERIA; PARADIGM; GENETICS;
D O I
10.1001/jamadermatol.2019.0891
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Key PointsQuestionIs hidradenitis suppurativa associated with inflammatory bowel disease? FindingsThis systematic review and meta-analysis included 5 case-control studies, 2 cross-sectional studies, and 1 cohort study with a total of 93601 unique participants with hidradenitis suppurativa who had 2.12-fold increased odds for Crohn disease and 1.51-fold increased odds for ulcerative colitis. One cohort study found a 5.6-fold increased risk of inflammatory bowel disease in patients with hidradenitis suppurativa. MeaningGastrointestinal tract symptoms, such as recurrent abdominal pain and chronic diarrhea, should not be overlooked in patients with hidradenitis suppurativa, and consultation with gastroenterologists should be sought. This systematic review and meta-analysis investigates the associated risk of inflammatory bowel disease in patients with hidradenitis suppurativa. ImportanceHidradenitis suppurativa (HS) and inflammatory bowel disease (IBD) are inflammatory diseases that share common genetic susceptibility and immunologic features. However, the link between HS and IBD has been largely unclear. ObjectiveTo conduct a meta-analysis to investigate the association between HS and IBD. Data SourcesA search of the MEDLINE, Cochrane Central Register of Controlled Trials, and Embase databases yielded 397 relevant studies from inception to June 10, 2018. Two additional studies were supplied by one of the investigators. Study SelectionCase-control, cross-sectional, or cohort studies that examined the odds or risk of IBD in patients with HS were included. No geographic or language limitations were imposed. Data Extraction and SynthesisThe Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed. The Newcastle-Ottawa Scale was used to assess the risk of bias of included studies. Crohn disease and ulcerative colitis were analyzed separately, and a random-effects model meta-analysis was conducted. Main Outcomes and MeasuresThe odds ratios (ORs) and hazard ratios (HRs) of IBD, Crohn disease, and ulcerative colitis in association with HS. ResultsFive case-control studies, 2 cross-sectional studies, and 1 cohort study with a total of 93601 unique participants were included. The meta-analysis of case-control and cross-sectional studies showed significant associations of HS with Crohn disease (pooled OR, 2.12; 95% CI, 1.46-3.08) and ulcerative colitis (pooled OR, 1.51; 95% CI, 1.25-1.82). Two case-control studies found significant association of HS with IBD (ORs, 2.16 [95% CI, 1.40-3.34] and 10.00 [95% CI, 1.94-51.50]). One cohort study found an increased risk of IBD in patients with HS (HR, 5.6; 95% CI not reported; P<.002). Conclusions and RelevanceThe evidence to date supports an association of HS with IBD. These results suggest that consultation with gastroenterologists should be sought when patients with HS present with recurrent abdominal pain, chronic diarrhea, bloody stool, and body weight loss.
引用
收藏
页码:1022 / 1027
页数:6
相关论文
共 50 条
[1]   MECHANISMS OF DISEASE Inflammatory Bowel Disease [J].
Abraham, Clara ;
Cho, Judy H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (21) :2066-2078
[2]   Hidradenitis suppurativa: A comprehensive review [J].
Alikhan, Ali ;
Lynch, Peter J. ;
Eisen, Daniel B. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (04) :539-561
[3]  
[Anonymous], 2010, SURGERY, DOI DOI 10.1016/J.SURG.2009.06.030
[4]  
[Anonymous], 2006, BMC MED RES METHODOL, DOI DOI 10.1186/1471-2288-6-52
[5]   Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies [J].
Baumgart, Daniel C. ;
Sandborn, William J. .
LANCET, 2007, 369 (9573) :1641-1657
[6]   Hidradenitis suppurativa association at the time of, or subsequent to, diagnosis of inflammatory bowel disease in a large US patient population [J].
Cices, A. ;
Ibler, E. ;
Majewski, S. ;
Huynh, T. ;
Sable, K. A. ;
Brieva, J. ;
West, D. P. ;
Nardone, B. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (07) :E311-E312
[7]   Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional study [J].
Deckers, Inge E. ;
Benhadou, Farida ;
Koldijk, Marjolein J. ;
del Marmol, Veronique ;
Horvath, Barbara ;
Boer, Jurr ;
van der Zee, Hessel H. ;
Prens, Errol P. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (01) :49-53
[8]   A genome-wide association study identifies IL23R as an inflammatory bowel disease gene [J].
Duerr, Richard H. ;
Taylor, Kent D. ;
Brant, Steven R. ;
Rioux, John D. ;
Silverberg, Mark S. ;
Daly, Mark J. ;
Steinhart, A. Hillary ;
Abraham, Clara ;
Regueiro, Miguel ;
Griffiths, Anne ;
Dassopoulos, Themistocles ;
Bitton, Alain ;
Yang, Huiying ;
Targan, Stephan ;
Datta, Lisa Wu ;
Kistner, Emily O. ;
Schumm, L. Philip ;
Lee, Annette T. ;
Gregersen, Peter K. ;
Barmada, M. Michael ;
Rotter, Jerome I. ;
Nicolae, Dan L. ;
Cho, Judy H. .
SCIENCE, 2006, 314 (5804) :1461-1463
[9]   Prevalence and Risk of Inflammatory Bowel Disease in Patients with Hidradenitis Suppurativa [J].
Egeberg, Alexander ;
Jemec, Gregor B. E. ;
Kimball, Alexa B. ;
Bachelez, Herve ;
Gislason, Gunnar H. ;
Thyssen, Jacob P. ;
Mallbris, Lotus .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) :1060-1064
[10]   The genetics of Crohn's disease and ulcerative colitis - status quo and beyond [J].
Ellinghaus, David ;
Bethune, Joern ;
Petersen, Britt-Sabina ;
Franke, Andre .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (01) :13-23